Consensus Statement on the Use of Botulinum Neurotoxin in the Middle East

Shazia Ali1 Department of Dermatology, University of Wales College of Medicine, Cardiff, Wales, UK;2 TrueMe Medical Centre, Jeddah, Kingdom of Saudi Arabi

Faten AL Bukhari3 Department of Dermatology, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia

https://orcid.org/0000-0002-8513-5726

Khaled Al Nuaimi4 Department of Dermatology, College of Medicine, Sharjah University, Sharjah, United Arab Emirates

Hossam Elenany5 Department of Dermatology and Aesthetic Medicine, DaO Derma, Cairo, Egypt

Nabil Fakih-Gomez6 Department of Facial Plastic Surgery, Fakih Hospital, Khaizaran, Lebanon

Sahar Ghannam7 Department of Dermatology, Alexandria University, Alexandria, Egypt

Rami Haidar8 Skin Experts Polyclinic, Dubai, United Arab Emirates

Nicanor Isse9 Department of Dermatology, Medcare Hospital and Clinics, Dubai, United Arab Emirates

Nancy Labib9 Department of Dermatology, Medcare Hospital and Clinics, Dubai, United Arab Emirates

Afshin Mosahebi10 Department of Plastic Surgery, Royal Free Hospital, London, UK

Simon Ravichandran11 Clinetix Rejuvenation Ltd, Glasgow, ScotlandCorrespondence[email protected]

Mohammed G Turkmani12 Derma Clinic, Riyadh, Kingdom of Saudi Arabi

Christeen Youssef13 Everlast Wellness Medical Center, Abu Dhabi, United Arab Emirates

show all

Consensus Statement on the Use of Botulinum Neurotoxin in the Middle East

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Consensus Statement on the Use of Botulinum Neurotoxin in the Middle East

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date